Answers are grounded in this paper and cite their sources.
Microsimulation model assesses disease progression in hereditary transthyretin amyloidosis with polyneuropathy, indicating earlier intervention benefits.
Use a microsimulation model to assess the impact of earlier diagnosis and treatment on disease progression in hereditary transthyretin amyloidosis with polyneuropathy (ATTRv-PN) in the US.
No takes yet. Share an insight, caveat, or question.
Halabi et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: